Experienced biopharmaceutical industry professional with progressive expertise in clinical research including Phases 1 through 4 site management, clinical trials management, clinical trial oversight and inspection readiness. Proficient in GCP, ICH E6, Health Canada Division 5, and FDA regulations.

• Atrial Fibrillation (device)
• Heart Failure
• Hypertension
• Sarcoidosis Associated Pulmonary Hypertension

• Atopic Dermatitis
• Psoriasis

• Crohn's Disease
• Dyslipidemia
• Diabetes
• Hepatitis C
• Irritable Bowel Syndrome (IBS)
• Obesity
• Ulcerative Colitis

• Acquired Hemophilia

• Huntington's Disease
• Parkinson's Disease

• Bladder Cancer
• Breast Cancer 
• Chronic Lymphocytic Lymphoma (CLL)
• Colorectal Cancer
• Multiple Myeloma
• Non-Hodgkin Lymphoma
• Non-Small Cell Lung Cancer (NSCLC)
• Prostate Cancer

• Duchenne Myelopathy

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Syncytial Virus (RSV) Vaccine

• Ankylosing Spondylitis 
• Lupus
• Psoriatic Arthritis
• Rheumatoid Arthritis (pediatric and adult population)

• English (Native or Bilingual Proficiency)
• French (Native or Bilingual Proficiency)
• Spanish (Professional Working Proficiency)
• German (Elementary Proficiency)